Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse

Journal of Addictive Diseases
R YoastH C Champion

Abstract

Extensive evaluation studies show that methadone maintenance therapy (MMT) reduces heroin use and associated problems in a cost-effective manner, without negative public health impact. MMT is limited by inadequate funding and understanding of relevant research, extensive regulation, and limits on the freedom of physicians to provide methadone in a variety of medical settings. Broad-based medical, public health, and scientific support exists for expansion of MMT with greater emphasis on consistency and quality, and provision of ancillary services. Programs for the exchange, free distribution, and legal pharmacy sale of needles and syringes reduce injection drug use and prevent the spread of bloodborne pathogens; drug abuse treatment and other services are important components. Neither strategy increases existing drug use nor leads to drug use initiation. The scientific literature supports assertions that drug abuse issues should be treated primarily as medical and public health rather than criminal justice issues. The effectiveness of both strategies warrants increased support for services, easing of federal and state restrictions governing their availability, and advocacy in their support.

References

Apr 22, 1992·JAMA : the Journal of the American Medical Association·V P Dole
Jan 1, 1991·Journal of Substance Abuse Treatment·D M Novick, H Joseph
Oct 1, 1990·British Journal of Addiction·E C BuningG Van Santen
Jan 1, 1989·Journal of Substance Abuse Treatment·A S FriedmanA Utada
Sep 1, 1988·Journal of Health and Social Behavior·J C BallS R Friedman
Jun 10, 1988·JAMA : the Journal of the American Medical Association·D M NovickM E Nyswander
Apr 1, 1995·Journal of Psychoactive Drugs·M Rosenbaum
Sep 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L A ValleroyW J Kassler
Sep 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S L GrosecloseW J Kassler
Apr 12, 1995·JAMA : the Journal of the American Medical Association·J W TapperoJ D Wenger
Jan 1, 1995·Journal of Substance Abuse Treatment·E A WellsA J Saxon
Sep 1, 1994·Journal of Substance Abuse Treatment·G Hagman
Oct 8, 1994·BMJ : British Medical Journal·G Morgan, A Willson
Jul 1, 1994·Journal of Substance Abuse Treatment·K J Miller
Jan 1, 1994·Journal of Psychoactive Drugs·L D Wenger, M Rosenbaum
Sep 10, 1994·BMJ : British Medical Journal·P WilsonG E Ralston
Apr 15, 1994·Structure·E J Goldsmith, J Mottonen
Jun 1, 1994·American Journal of Public Health·W MandellS Cohn
Jan 1, 1993·Addiction·J R CaplehornV J Gebski
Jan 1, 1995·The International Journal of the Addictions·D PaoneS R Friedman
Aug 1, 1996·Archives of General Psychiatry·P Crits-Christoph, L Siqueland
Aug 1, 1996·American Journal of Public Health·S BurrisJ Grace
Jan 1, 1997·Journal of Addictive Diseases·M Herman, M N Gourevitch
Apr 1, 1997·Journal of Psychoactive Drugs·J T Payte
Jul 1, 1997·The American Journal on Addictions·J F MadduxK N Vogtsberger
Aug 1, 1997·The American Journal of Drug and Alcohol Abuse·E B Robertson, J F Donnermeyer
Jan 8, 1998·American Journal of Epidemiology·P Lurie
Feb 12, 1998·Medical Anthropology·J B Page
May 16, 1998·American Journal of Public Health·H M RhoadesJ Grabowski
May 21, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J BlakesleeP L Triozzi
May 21, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·F X Mbopi KéouL Bélec
Jun 20, 1998·JAMA : the Journal of the American Medical Association·P S Rosenberg, R J Biggar
Jun 24, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D G Contopoulos-Ioannidis, J P Ioannidis
Jul 2, 1998·Cancer Genetics and Cytogenetics·N M LindorS N Thibodeau
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M J Alter, L A Moyer
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R S GarfeinD Vlahov
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R R Gershon

❮ Previous
Next ❯

Citations

Aug 28, 2009·BMC Medical Ethics·Louise-Anne McNuttAnneli Uusküla
Sep 28, 2005·Journal of Addictive Diseases·Josiah D RichJennifer Clarke
Sep 28, 2005·Journal of Addictive Diseases·Thomas M BradyPing Yu
Dec 29, 2007·The American Journal of Drug and Alcohol Abuse·Lijun YangWeixian Cheng
Dec 15, 2006·Journal of Psychoactive Drugs·Corrine E Munoz-PlazaHolly Hagan
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick L AlticeLois Eldred
Feb 22, 2005·Journal of Interpersonal Violence·Marianne R Yoshioka, Deborah Y Choi
Oct 3, 2006·Current Opinion in Psychiatry·Christian Haasen, Wim van den Brink
Mar 26, 2010·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·M FischerC Haasen
Apr 9, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Andrew BalmfordGeorgina M Mace
Nov 23, 2019·The American Journal of Drug and Alcohol Abuse·Bryon Adinoff, Ziva D Cooper
Jan 4, 2003·Substance Use & Misuse·Elise D RileyDavid Vlahov
Oct 21, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Wim Van den Brink, Christian Haasen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.